266 related articles for article (PubMed ID: 17977725)
1. Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain.
González FV; Izquierdo J; Rodríguez S; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 2007 Dec; 17(24):6697-700. PubMed ID: 17977725
[TBL] [Abstract][Full Text] [Related]
2. Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.
Royo S; Schirmeister T; Kaiser M; Jung S; Rodríguez S; Bautista JM; González FV
Bioorg Med Chem; 2018 Sep; 26(16):4624-4634. PubMed ID: 30037754
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
4. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
7. Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
Mott BT; Ferreira RS; Simeonov A; Jadhav A; Ang KK; Leister W; Shen M; Silveira JT; Doyle PS; Arkin MR; McKerrow JH; Inglese J; Austin CP; Thomas CJ; Shoichet BK; Maloney DJ
J Med Chem; 2010 Jan; 53(1):52-60. PubMed ID: 19908842
[TBL] [Abstract][Full Text] [Related]
8. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
Roush WR; González FV; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
[TBL] [Abstract][Full Text] [Related]
10. Allicin and derivates are cysteine protease inhibitors with antiparasitic activity.
Waag T; Gelhaus C; Rath J; Stich A; Leippe M; Schirmeister T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5541-3. PubMed ID: 20692829
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
Maiorana S; Ettari R; Previti S; Amendola G; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M
ChemMedChem; 2020 Aug; 15(16):1552-1561. PubMed ID: 32567172
[TBL] [Abstract][Full Text] [Related]
13. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV
Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole inhibitors of the major cysteine protease of
Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
[No Abstract] [Full Text] [Related]
15. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
[TBL] [Abstract][Full Text] [Related]
16. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
[TBL] [Abstract][Full Text] [Related]
17. Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids.
Breuning A; Degel B; Schulz F; Büchold C; Stempka M; Machon U; Heppner S; Gelhaus C; Leippe M; Leyh M; Kisker C; Rath J; Stich A; Gut J; Rosenthal PJ; Schmuck C; Schirmeister T
J Med Chem; 2010 Mar; 53(5):1951-63. PubMed ID: 20131843
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action.
Royo S; Rodríguez S; Schirmeister T; Kesselring J; Kaiser M; González FV
ChemMedChem; 2015 Sep; 10(9):1484-7. PubMed ID: 26179752
[TBL] [Abstract][Full Text] [Related]
20. Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.
Ettari R; Pinto A; Previti S; Tamborini L; Angelo IC; La Pietra V; Marinelli L; Novellino E; Schirmeister T; Zappalà M; Grasso S; De Micheli C; Conti P
Bioorg Med Chem; 2015 Nov; 23(21):7053-60. PubMed ID: 26432608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]